318 related articles for article (PubMed ID: 18219819)
21. The effect of dexamethasone on L-alpha-lysophosphatidyl choline (lysolecithin)-induced demyelination of the rat spinal cord.
Triarhou LC; Herndon RM
Arch Neurol; 1986 Feb; 43(2):121-5. PubMed ID: 3947247
[TBL] [Abstract][Full Text] [Related]
22. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination.
Mullin AP; Cui C; Wang Y; Wang J; Troy E; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E
Neurobiol Dis; 2017 Sep; 105():142-155. PubMed ID: 28576706
[TBL] [Abstract][Full Text] [Related]
23. Spontaneous and induced remyelination in multiple sclerosis and the Theiler's virus model of central nervous system demyelination.
Miller DJ; Rodriguez M
Microsc Res Tech; 1995 Oct; 32(3):230-45. PubMed ID: 8527857
[TBL] [Abstract][Full Text] [Related]
24. Spontaneous central nervous system remyelination is not altered in NFH-lacZ transgenic mice after chemical demyelination.
Jean I; Fressinaud C
J Neurosci Res; 2003 Jul; 73(1):54-60. PubMed ID: 12815708
[TBL] [Abstract][Full Text] [Related]
25. Multiexponential T2 and magnetization transfer MRI of demyelination and remyelination in murine spinal cord.
McCreary CR; Bjarnason TA; Skihar V; Mitchell JR; Yong VW; Dunn JF
Neuroimage; 2009 May; 45(4):1173-82. PubMed ID: 19349232
[TBL] [Abstract][Full Text] [Related]
26. Demyelinating diseases and potential repair strategies.
Radtke C; Spies M; Sasaki M; Vogt PM; Kocsis JD
Int J Dev Neurosci; 2007 May; 25(3):149-53. PubMed ID: 17408905
[TBL] [Abstract][Full Text] [Related]
27. A novel model to measure the regenerative potential of the peripheral nervous system after experimental immunological demyelination.
Kosins AM; McConnell MP; Mendoza C; Shepard B; Scholz T; Evans GRD; Keirstead HS
Plast Reconstr Surg; 2009 Jun; 123(6):1688-1696. PubMed ID: 19483567
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of central nervous system remyelination in immune and non-immune experimental models of demyelination.
van Engelen BG; Pavelko KD; Rodriguez M
Mult Scler; 1997 Apr; 3(2):76-9. PubMed ID: 9291157
[TBL] [Abstract][Full Text] [Related]
29. Remyelination in the CNS: from biology to therapy.
Franklin RJ; Ffrench-Constant C
Nat Rev Neurosci; 2008 Nov; 9(11):839-55. PubMed ID: 18931697
[TBL] [Abstract][Full Text] [Related]
30. Acceleration in the rate of CNS remyelination in lysolecithin-induced demyelination.
Pavelko KD; van Engelen BG; Rodriguez M
J Neurosci; 1998 Apr; 18(7):2498-505. PubMed ID: 9502810
[TBL] [Abstract][Full Text] [Related]
31. Human antibodies accelerate the rate of remyelination following lysolecithin-induced demyelination in mice.
Bieber AJ; Warrington A; Asakura K; Ciric B; Kaveri SV; Pease LR; Rodriguez M
Glia; 2002 Mar; 37(3):241-9. PubMed ID: 11857682
[TBL] [Abstract][Full Text] [Related]
32. Thin myelin sheaths as the hallmark of remyelination persist over time and preserve axon function.
Duncan ID; Marik RL; Broman AT; Heidari M
Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9685-E9691. PubMed ID: 29078396
[TBL] [Abstract][Full Text] [Related]
33. The use of cultured autologous Schwann cells to remyelinate areas of persistent demyelination in the central nervous system.
Blakemore WF; Crang AJ
J Neurol Sci; 1985 Sep; 70(2):207-23. PubMed ID: 4056820
[TBL] [Abstract][Full Text] [Related]
34. Two-photon imaging of remyelination of spinal cord axons by engrafted neural precursor cells in a viral model of multiple sclerosis.
Greenberg ML; Weinger JG; Matheu MP; Carbajal KS; Parker I; Macklin WB; Lane TE; Cahalan MD
Proc Natl Acad Sci U S A; 2014 Jun; 111(22):E2349-55. PubMed ID: 24843159
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological treatment promoting remyelination enhances motor function after internal capsule demyelination in mice.
Yamazaki R; Osanai Y; Kouki T; Huang JK; Ohno N
Neurochem Int; 2023 Mar; 164():105505. PubMed ID: 36754122
[TBL] [Abstract][Full Text] [Related]
36. Application of q-Space Diffusion MRI for the Visualization of White Matter.
Fujiyoshi K; Hikishima K; Nakahara J; Tsuji O; Hata J; Konomi T; Nagai T; Shibata S; Kaneko S; Iwanami A; Momoshima S; Takahashi S; Jinzaki M; Suzuki N; Toyama Y; Nakamura M; Okano H
J Neurosci; 2016 Mar; 36(9):2796-808. PubMed ID: 26937016
[TBL] [Abstract][Full Text] [Related]
37. The expression of myelin protein mRNAs during remyelination of lysolecithin-induced demyelination.
Woodruff RH; Franklin RJ
Neuropathol Appl Neurobiol; 1999 Jun; 25(3):226-35. PubMed ID: 10417664
[TBL] [Abstract][Full Text] [Related]
38. Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin.
Wang C; Kotter MR
Methods Mol Biol; 2018; 1791():233-241. PubMed ID: 30006714
[TBL] [Abstract][Full Text] [Related]
39. Increased mitochondrial content in remyelinated axons: implications for multiple sclerosis.
Zambonin JL; Zhao C; Ohno N; Campbell GR; Engeham S; Ziabreva I; Schwarz N; Lee SE; Frischer JM; Turnbull DM; Trapp BD; Lassmann H; Franklin RJ; Mahad DJ
Brain; 2011 Jul; 134(Pt 7):1901-13. PubMed ID: 21705418
[TBL] [Abstract][Full Text] [Related]
40. An ultrastructural study of experimental demyelination and remyelination. V. Central and peripheral nervous system lesions caused by diphtheria toxin.
Wiśniewski H; Raine CS
Lab Invest; 1971 Jul; 25(1):73-80. PubMed ID: 5555698
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
